GOVERNMENT
HHS Ousts Dr. Peter Marks with Biopharma Lamenting Loss of ‘Ally’ at FDA
. ER Editor: We offer some interesting items on Dr. Peter Marks’ ‘resignation’ from the FDA. A reminder that Marks has probably been gone for some time. EO 13818 in 2017 was designed specifically with […]